BACKGROUND
In transthyretin amyloid cardiomyopathy, mitral regurgitation (MR) severity may be underestimated by conventional (semi-)quantitative echocardiographic criteria due to restrictive low-flow hemodynamics. We sought to define and validate disease-specific MR risk thresholds and compare their prognostic performa...
L. Hauptmann, C. Kronberger, S. Schwarting et al.· Circulation· 0 citations
BACKGROUND
The effect of transcatheter tricuspid-valve repair on clinical outcomes, including death and hospitalization for heart failure, in patients with severe tricuspid regurgitation remains uncertain.
METHODS
We randomly assigned patients with symptomatic severe tricuspid regurgitation and an increased risk of f...
J. Hausleiter, T. Stocker, Tobias Geisler et al.· New England Journal of Medic...· 8 citations· ⚡1
OBJECTIVES
Tricuspid regurgitation (TR) is associated with high morbidity and mortality. The TricValve bicaval valve system has emerged as a transcatheter option for patients with severe symptomatic TR who are not candidates for surgery or orthotopic interventions. However, its safety in patients with pre-existing card...
K. Osipenko, Iuliana Coti, Paul Werner et al.· European Journal of Cardio-T...· 0 citations
TTVR with the LuX-Valve Plus system to treat patients with severe or greater symptomatic TR and a large tricuspid annulus was associated with high intraprocedural and 30-day clinical success rates, significant TR reduction and functional improvement, and low permanent pacemaker implantation rates.
O. de Backer, Y. Lim, R. von Bardeleben et al.· EuroIntervention· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.